Details for New Drug Application (NDA): 072036
✉ Email this page to a colleague
NDA 072036 describes NUPRIN, which is a drug marketed by Bristol Myers and Kenvue Brands and is included in three NDAs. It is available from two suppliers. Additional details are available on the NUPRIN profile page.
The generic ingredient in NUPRIN is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and forty-five suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
The generic ingredient in NUPRIN is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and forty-five suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Summary for 072036
| Tradename: | NUPRIN |
| Applicant: | Bristol Myers |
| Ingredient: | ibuprofen |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 072036
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
| Approval Date: | Feb 16, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
